CaliPharms, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KGET research report →
About the company
CaliPharms, Inc. is an entity actively engaged in the medicinal cannabis industry across the United States. The company's primary focus lies within the THC and CBD-infused beverage sector.
- CEO
- Eric Watson
- IPO
- 2013
- Employees
- 4
- HQ
- Temecula, US
Price Chart
- Market Cap
- $474.35K
- P/E
- -0.40
- P/S
- 39.53
- P/B
- -0.11
- EV/EBITDA
- -0.62
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -11222.67%
- Net Margin
- -11861.40%
- ROE
- 19.88%
- ROIC
- 37.43%
- Revenue
- $12.00K · 0.00%
- Net Income
- $-1,423,368 · -222.33%
- EPS
- $-0.00 · 0.00%
- Op Income
- $-1,346,720
- FCF YoY
- -1445.28%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -58.74
- Avg Volume
- 3.73M
Get TickerSpark's AI analysis on KGET
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our KGET coverage
Recent articles, reports, and earnings notes.
No research on KGET yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KGET report →Similar companies
Peers in the same neighborhood.